Marty M - Search Results

1

Risk of breast cancer by individual insulin use: an international multicenter study.

Grimaldi-Bensouda L, Cameron D, Marty M, Barnett AH, Penault-Llorca F, Pollak M, Charbonnel B, Riddle M, Mignot L, Boivin JF, Khachatryan A, Rossignol M, Bénichou J, Alpérovitch A, Abenhaim L; ISICA Group. Grimaldi-Bensouda L, et al. Among authors: marty m. Diabetes Care. 2014;37(1):134-43. doi: 10.2337/dc13-0695. Epub 2013 Aug 15. Diabetes Care. 2014. PMID: 23949559

2

The international study of insulin and cancer.

Grimaldi-Bensouda L, Marty M, Pollak M, Cameron D, Riddle M, Charbonnel B, Barnett AH, Boffetta P, Boivin JF, Evans M, Rossignol M, Benichou J, Abenhaim L; ISICA group. Grimaldi-Bensouda L, et al. Among authors: marty m. Lancet. 2010 Sep 4;376(9743):769-70. doi: 10.1016/S0140-6736(10)61374-8. Lancet. 2010. PMID: 20816540 No abstract available.

3

[Pregnancy after treated breast cancer. Results of a case-control study].

Mignot L, Morvan F, Berdah J, Querleu D, Laurent JC, Verhaeghe M, Fontaine F, Marin JL, Gorins A, Marty M. Mignot L, et al. Among authors: marty m. Presse Med. 1986 Nov 8;15(39):1961-4. Presse Med. 1986. PMID: 2947219 French.

4

Gastric metastases from breast cancer: a retrospective series of 12 patients.

Zelek L, Cottu PH, Mignot L, de Roquancourt A, Fizazi K, Cojean-Zelek I, Espie M, Marty M. Zelek L, et al. Among authors: marty m. Am J Clin Oncol. 2001 Aug;24(4):363-5. doi: 10.1097/00000421-200108000-00009. Am J Clin Oncol. 2001. PMID: 11474262

5

High-dose epirubicin and cyclophosphamide every two weeks as first-line chemotherapy for relapsing metastatic breast cancer patients.

Cottu PH, Zelek L, Extra JM, Espie M, Mignot L, Morvan F, Marty M. Cottu PH, et al. Among authors: marty m. Ann Oncol. 1999 Jul;10(7):795-801. doi: 10.1023/a:1008353904351. Ann Oncol. 1999. PMID: 10470426 Free article. Clinical Trial.

6

Efficacy and tolerance of vinorelbine and fluorouracil combination as first-line chemotherapy of advanced breast cancer: results of a phase II study using a sequential group method.

Dieras V, Extra JM, Bellissant E, Espie M, Morvan F, Pierga JY, Mignot L, Tresca P, Marty M. Dieras V, et al. Among authors: marty m. J Clin Oncol. 1996 Dec;14(12):3097-104. doi: 10.1200/JCO.1996.14.12.3097. J Clin Oncol. 1996. PMID: 8955654 Clinical Trial.

7

Progression-free survival as surrogate end point for overall survival in clinical trials of HER2-targeted agents in HER2-positive metastatic breast cancer.

Michiels S, Pugliano L, Marguet S, Grun D, Barinoff J, Cameron D, Cobleigh M, Di Leo A, Johnston S, Gasparini G, Kaufman B, Marty M, Nekljudova V, Paluch-Shimon S, Penault-Llorca F, Slamon D, Vogel C, von Minckwitz G, Buyse M, Piccart M. Michiels S, et al. Among authors: marty m. Ann Oncol. 2016 Jun;27(6):1029-1034. doi: 10.1093/annonc/mdw132. Epub 2016 Mar 8. Ann Oncol. 2016. PMID: 26961151 Free article.

8

[The principal anticancer agents].

Marty M, Gisselbrecht C, Mignot L, Unger P, Boiron M. Marty M, et al. Rev Prat. 1981 Oct 1;31(43):2979-80 passim. Rev Prat. 1981. PMID: 7291906 French. No abstract available.

9

Phase II randomized study of paclitaxel versus mitomycin in advanced breast cancer.

Dieras V, Marty M, Tubiana N, Corette L, Morvan F, Serin D, Mignot L, Chazard M, Garet F, Onetto N, et al. Dieras V, et al. Among authors: marty m. Semin Oncol. 1995 Aug;22(4 Suppl 8):33-9. Semin Oncol. 1995. PMID: 7638640 Clinical Trial.

10

Phase I study of oxaliplatin in patients with advanced cancer.

Extra JM, Espie M, Calvo F, Ferme C, Mignot L, Marty M. Extra JM, et al. Among authors: marty m. Cancer Chemother Pharmacol. 1990;25(4):299-303. doi: 10.1007/BF00684890. Cancer Chemother Pharmacol. 1990. PMID: 2295116

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

784 results

Search Page